Russia completes clinical trials of second potential COVID-19 vaccine
Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia’s Vector Institute, the RIA news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Wednesday.
The institute completed early-stage human trials, known as Phase II, earlier this month.
SOURCE: REUTERS
PHOTO: FILE PHOTO: Small toy figures are seen in front of a Covid-19 Vaccine logo in this illustration taken. REUTERS
The Times of Earth ( TOE) founded in 1999, is a multilingual newspaper that is printed and circulated in many countries including some parts of the United States and Canada. It is considered as the largest trusted & respected international multimedia news/financial information source of the world.